Showing 9401-9410 of 18069 results for "".
- Efgartigimod in Rheumatology: Evaluating Its Impact on Myositis and Sjogren’s Diseasehttps://reachmd.com/news/efgartigimod-in-rheumatology-evaluating-its-impact-on-myositis-and-sjogrens-disease/2475317/Argenx has unveiled promising Phase 2 results for efgartigimod in both idiopathic inflammatory myopathies (IIM) and primary Sjögren’s di
- Emerging Approaches in Glaucoma Treatment: The Role of QLS-111 in Intraocular Pressure (IOP) Managementhttps://reachmd.com/news/emerging-approaches-in-glaucoma-treatment-the-role-of-qls-111-in-intraocular-pressure-iop-management/2475299/Persistent challenges in intraocular pressure control and patient adherence have led to the development of novel agents. QLS-111, which modulates ATP-sensitive potassium channels—proteins that help regulate cellular activity by controlling po
- Environmental and Dietary Influences on Hormone Regulation: A Dual-Front Challenge in Endocrinologyhttps://reachmd.com/news/environmental-and-dietary-influences-on-hormone-regulation-a-dual-front-challenge-in-endocrinology/2475308/As environmental and dietary factors increasingly interact, their combined influence on hormone regulation is becoming a focal point of endocrinological concern. Clinicians are now grappling with a dual-front challenge: silent exposome
- How Environmental Metal Exposure Is Shaping Heart Failure Risk: Insights for Cardiologistshttps://reachmd.com/news/how-environmental-metal-exposure-is-shaping-heart-failure-risk-insights-for-cardiologists/2475311/A recent Columbia University cohort analysis has highlighted the surprising influence of
- Revolutionizing Brain Imaging: PET’s Role in Early Neuroinflammation Detectionhttps://reachmd.com/news/revolutionizing-brain-imaging-pets-role-in-early-neuroinflammation-detection/2475301/Recent advancements in PET imaging have enabled the detection of early neuroinflammatory changes in condit
- Capsule Sponge Test: A Non-Invasive Alternative for Barrett's Esophagus Monitoringhttps://reachmd.com/news/capsule-sponge-test-a-non-invasive-alternative-for-barretts-esophagus-monitoring/2475309/The capsule sponge test offers a less invasive option for Barrett's esophagus monitoring, providing a patient-friendly approach that could improve compliance and streamline care. Monitoring Barrett’s esophagus has long posed a dilemma
- Innovative Strategies to Combat Antibacterial Resistance in Klebsiella pneumoniaehttps://reachmd.com/news/innovative-strategies-to-combat-antibacterial-resistance-in-klebsiella-pneumoniae/2475303/Antibacterial resistance in Klebsiella pneumoniae is increasingly concerning as carbapenem-resistant strains co-opt biofilm formation to hinder last-line therapies, highlighting the need for innovative treatment strategies. Infectious
- Evolving Monitoring Modalities Transforming ICU Ventilator Support and Brain Activity Assessmenthttps://reachmd.com/news/evolving-monitoring-modalities-transforming-icu-ventilator-support-and-brain-activity-assessment/2475310/Evolving monitoring modalities such as diaphragm electromyography (EMG) and near-infrared spectroscopy are transforming how intensivists tailor ventilator support and assess brain activity, directly influencing patient trajectories and recove
- Antibiotic Resistance and Global Food Chains: A Call for Immediate Actionhttps://reachmd.com/news/antibiotic-resistance-and-global-food-chains-a-call-for-immediate-action/2475287/Antibiotic resistance is accelerating at the intersection of global food chains and zoonotic pathogens, demanding urgent attention from clinicians and public health leaders. Clinicians face an escalating challenge as antimicrobial stew
- Integrating Ketamine Therapy with Psychotherapy for Treatment-Resistant Severe Depression: Clinical Advances and Considerationshttps://reachmd.com/news/integrating-ketamine-therapy-with-psychotherapy-for-treatment-resistant-severe-depression-clinical-advances-and-considerations/2475294/As psychiatrists confront a rising tide of treatment-resistant severe depression, innovative strategies beyond traditional monoaminergic therapies are reshaping practice. A pivotal shift in severe depression treatment has emerged with